Expanding business and trade with CIS Region — Healthcare
Suggestions/issues invited for expanding trade with CIS Region with healthcare companies
Abhishek Singh CEO Taj Pharmaceuticals India states that; there is a general awareness about the, CIS Region (Commonwealth of Independent States) consists of 12 countries namely Kazakhstan, Turkmenistan, Uzbekistan, Kyrgyzstan, Tajikistan, Russian Federation, Georgia, Azerbaijan, Armenia, Ukraine, Belarus and Moldova.
India’s major healthcare exports to CIS countries includes Pharmaceutical products, Electrical machinery and equipment and parts thereof, Machinery, Mechanical appliances, Organic chemicals; Coffee, tea, spices, Vehicles other than railway or tramway rolling stock, and parts and accessories thereof, Iron and steel etc.
It is observed that in spite of large market size and great potential, India’s exports to the CIS region was USD 5.3 Billion in 2019, and constituted only 1.2% in overall CIS imports. In order to enhance India’ share and volume in CIS imports, Department of Commerce has requested to identify the issues/reasons for low penetration and measures required to be taken to increase our trade.
In case you have any inputs/suggestions in this regard, kindly send us the same(Country wise) latest by June 20th, 2020 at info@tajpharma.com to enable us to forward the same to the Indian Ministry’s so that the same can be taken up with the respective authorities.
About Taj Pharma Russia and CIS operations (ТАДЖ ФАРМА)
TAJ PHARMA CIS (ТАДЖ ФАРМА) is Russia’s leading innovative Generics and branded Pharmaceuticals Company; it combines a world-class research and development center, ultra-modern pharmaceutical and generics manufacturing facilities, as well as preclinical and clinical research infrastructure compliant with international standards to develop first generics.
TAJ PHARMA CIS (ТАДЖ ФАРМА) is one of the world`s few full-cycle generic drug development and manufacturing companies, from new molecule discovery and first bio-similar’s to large-scale commercial production and marketing support.
TAJ PHARMA CIS (ТАДЖ ФАРМА)`s medicines are dedicated to treat complex health conditions such as renal insufficiency, Cancer, Hepatitis C and HIV infections and other disorders.
Taj Pharma CIS offers a range of “comprehensive” product registration, marketing authorization, in-licensing and out-licensing of pharmaceuticals products; and holds expertise to register pharmaceuticals products from formulation design up to international products registration and distribution. We specialize in the marketing, distribution, product registration of an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids, Pre-filled syringes and high-potency products.
We hold top positions in established Moscow and Turkmenistan, Baku, Azerbaijan, Kazakhstan etc; with our unique products and are building a strong presence in many CIS markets.
Philosophy
Focus on niche product manufacturing platforms, combining cutting-edge technology and the best minds in the business.
Quality
Quality has always been a strong part of Taj Pharma proposition. Our flagship infrastructures covers all aspects including product quality, GMP manufacturing, operational quality and environmental quality.
Vision
To provide integrated model gives our customer cost effective and efficient manner
Mission
Taj Pharma CIS is a vertically integrated pharmaceutical licensing and distribution company with established research, manufacturing and marketing capabilities across multi-therapeutic domains.
Our Satisfied Customers
TAJ PHARMA CIS (ТАДЖ ФАРМА) is Russia’s leading innovative Generics and branded pharmaceuticals company; it combines a world-class research and development center, ultra-modern pharmaceutical and generics manufacturing facilities, as well as preclinical and clinical research infrastructure compliant with international standards to develop first generics.
TAJ PHARMA CIS (ТАДЖ ФАРМА) is one of the world`s few full-cycle generic drug development and manufacturing companies, from new molecule discovery and first bio-similar’s to large-scale commercial production and marketing support.
TAJ PHARMA CIS (ТАДЖ ФАРМА)`s medicines are dedicated to treat complex health conditions such as renal insufficiency, Cancer, Hepatitis C and HIV infections and other disorders.
Key Factors:-
- 4500 *Generic Compositions
- 64 *First Generics
- 60 *Product Pipeline
- 28 *Distribution Countries
The core
The core of our business is combining creativity and professionalism in solving problems. Patience and painstaking hard work is our formula for successful achievement of our goals.
Our Vision
To provide integrated model that gives our customer cost effective and efficient manner
Our mission
Our mission is increasing life expectancy and improving quality of life.
Philosophy
Focus on niche product distribution platforms, combining cutting-edge technology and the best minds in the business.
Mission
Taj Pharma CIS is a vertically integrated pharmaceutical company with established distribution and marketing capabilities across multi-therapeutic domains. Our core mission is increasing life expectancy and improving quality of life.
Quality
Quality has always been a strong part of Taj Pharma’s proposition. Our quality initiative covers all aspects including product quality, operational quality and environmental quality.
Our business
We work towards the accumulation of advanced generics, which enables us to unlock the revolutionary potential for creating optimal conditions for patients to live happier lives.
Taj Pharma Russia & CIS flexible to work client- comfort models of Business to undertake a wide range of projects on a molecule basis.
Pre-formulations and Incompatibility studies
Taj Pharma CIS will performs an extensive and detailed study report on incompatibility for drug substance with excipients and packing materials.
Taj CIS works under Generic and Branded Formulation Development.
Russia is growing like never before under capable leadership of President Mr. Vladmir Putin- Ms. Priyanka Singh Director Taj Pharma Group